Bersiporocin
(2R,3S)-2-[3-(4,5-dichlorobenzimidazol-1-yl)propyl]piperidin-3-ol
Molecular Identity
Bersiporocin
(2R,3S)-2-[3-(4,5-dichlorobenzimidazol-1-yl)propyl]piperidin-3-ol
PubChem CID: 142411678
2D Structure
Properties
C15H19Cl2N3O
Molecular Formula
328.20
Molecular Weight
g/mol
327.0905
Exact Mass
Da
2.8
XLogP
Drug-like (Lipinski: < 5)
50.1
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
3
H-Bond Acceptors
347
Complexity
SMILES
Canonical SMILES
SMILES: C1CC(C(NC1)CCCN2C=NC3=C2C=CC(=C3Cl)Cl)OIsomeric SMILES
SMILES: C1C[C@@H]([C@H](NC1)CCCN2C=NC3=C2C=CC(=C3Cl)Cl)OSynonyms(20)
BersiporocinUNII-TTU6QSK1G5TTU6QSK1G5DWN-12088BERSIPOROCIN [INN]RefChem:1190992241808-52-4DWN12088(2R,3S)-2-(3-(4,5-Dichloro-1H-benzo(d)imidazol-1-yl)propyl)piperidin-3-ol(2R,3S)-2-[3-(4,5-dichlorobenzimidazol-1-yl)propyl]piperidin-3-ol(2R,3S)-2-[3-[4,5-bis(chloranyl)benzimidazol-1-yl]propyl]piperidin-3-ol3-Piperidinol, 2-(3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl)-, (2R,3S)BersiporocinaBersiporocineBersiporocin (USAN/INN)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Bersiporocin
Loading drug network...